6533b853fe1ef96bd12ad055

RESEARCH PRODUCT

R-Rescovitine (Seliciclib) inhibits DNA damage-induced Cyclin A1 up-regulation and hinders non-homologous end joining: a rationale for therapeutic combinations with DNA damaging agents.

Mario Federico

subject

Settore MED/06 - Oncologia Medicahinders non-homologous end joiningtherapeutic combinationR_Rescovitine inhibits DNA damage-induced Cyclin A1 up-regulationhttp://hdl.handle.net/10447/105201